Skip to main content

Michael P. Chrissoheris, MD

12/02/2011
ABSTRACT: Transcatheter aortic valve implantation is emerging as a promising, effective therapy for high-risk patients not eligible to undergo surgical aortic valve replacement. Infection complications have only rarely been reported. We...
ABSTRACT: Transcatheter aortic valve implantation is emerging as a promising, effective therapy for high-risk patients not eligible to undergo surgical aortic valve replacement. Infection complications have only rarely been reported. We...
ABSTRACT: Transcatheter aortic...
12/02/2011
Journal of Invasive Cardiology
Case Report
04/07/2009
From the Division of Cardiology, Hospital of Saint Raphael, New Haven, Connecticut. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 20, 2008, and accepted December 3, 2008. Address for...
From the Division of Cardiology, Hospital of Saint Raphael, New Haven, Connecticut. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 20, 2008, and accepted December 3, 2008. Address for...
From the Division of Cardiology,...
04/07/2009
Journal of Invasive Cardiology
08/05/2014
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) seems to be an effective and promising procedure in patients with degenerated bioprosthetic aortic valves, avoiding the risks associated with the use of cardioplegia and redo...
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) seems to be an effective and promising procedure in patients with degenerated bioprosthetic aortic valves, avoiding the risks associated with the use of cardioplegia and redo...
Valve-in-valve (ViV)...
08/05/2014
Journal of Invasive Cardiology